Skip to main content
OpenTrials
Completed

NCT Number: NCT04924348

WALANT Procedure in Carpal Tunnel Release

The possible benefits expected from the use of the WALANT procedure are a decrease in intraoperative pain at the surgical site, a decrease in hospitalization time, and a decrease in the time required to lift the anesthesia postoperatively.

The risks identified are those inherent to each type of anesthesia (WALANT or traditional ALR), as encountered in current practice, and are therefore not specific to the study: risks related to the local anesthetic agent or risks related to the puncture procedure.

The main objective is to determine whether the patient's intraoperative pain at the surgical site is less after a WALANT procedure compared to a traditional ALR procedure (axillary or trunk).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institut de la main Nantes Atlantique

Saint-Herblain, 44800, France

About this study

Median nerve neurolysis at the carpal tunnel is one of the most performed procedures in the world. The use of loco-regional anesthesia (LRA) is common practice for this surgery, especially since the use of ultrasound guidance, which allows visualization of the nerves and control of the injection of anesthetic products, makes it a safe technique. The nerve blocks most commonly used in hand surgery are axillary blocks and truncal blocks. The choice between these two techniques, which are equivalent in terms of effectiveness and duration of anesthesia, depends in practice on the habits of each practitioner. As the use of a pneumatic tourniquet during the operation is systematic, the axillary block, by anaesthetizing the whole arm, avoids the discomfort described by some patients when using a tourniquet. For others, the discomfort is related to the sensation of a "dead arm" with a duration of anesthesia of several hours, which the truncular block makes it possible to avoid.

Recently, an alternative to traditional LRA by local anesthesia without tourniquet and without sedation (WALANT procedure: Wide Awake Local Anesthesia with No Tourniquet) has been described. Several studies show the efficacy and safety of this procedure, which is already used in current practice.

However, to date, there is no comparative study evaluating the effectiveness of the WALANT procedure compared to traditional hand surgery techniques for carpal tunnel, neither published nor in progress. This is the purpose of this study.

The WALANT technique, performed under ultrasound, includes two punctures.

  • The first is a puncture through a medial approach above the wrist and includes two injections. A first subcutaneous injection reproducing a bar above the wrist flexion line, and a second injection above the median nerve. The volumes injected vary from 8 to 10 milliliters (ml).
  • The second puncture is performed at the base of the palmar surface of the hand and consists of a 10 ml subcutaneous injection of the local anesthetic in order to take advantage of the vasoconstrictive effects of adrenaline, thus allowing the surgical procedure to be performed without a pneumatic tourniquet.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patient over 18 years of age
  • Membership in a mandatory health insurance plan
  • Patient treated for a first median nerve liberation surgery at the carpal tunnel
  • Patient having been informed of the study and having given informed consent
  • French-speaking patient

Exclusion criteria

  • Surgical revision
  • Contraindication(s) to loco-regional anesthesia :
  • Coagulation disorder or ongoing anticoagulant therapy
  • Existing peripheral neuropathy
  • Amide-type AL allergy
  • Pregnant or breastfeeding women
  • Inability to undergo the medical follow-up of the study for geographical, social or psychological reasons
  • Patients under legal protection
  • Patients under the influence of drugs that may interfere with the anesthetic techniques under study (cocaine, cannabis, etc. as judged by the investigator)
  • Inclusion of the subject in another research protocol during this study

Treatment and study plan

Experimental: WALANT procedure

Procedure

The WALANT technique, performed under ultrasound, includes two punctures.

  • The first is a puncture through a medial approach above the wrist and includes two injections. A first subcutaneous injection reproducing a bar above the wrist flexion line, and a second injection above the median nerve. The volumes injected vary from 8 to 10 milliliters (ml).
  • The second puncture is performed at the base of the palmar surface of the hand and consists of a 10 ml subcutaneous injection of the local anesthetic in order to take advantage of the vasoconstrictive effects of adrenaline, thus allowing the surgical procedure to be performed without a pneumatic tourniquet.

Active Comparator: Axial ALR

Procedure

The anesthetic protocol in the axillary block consists of performing a puncture, using a needle (50 mm 22G with a short bevel), under the armpit at the level of the axillary hollow after skin disinfection. This puncture, performed under ultrasound, allows the injection of the local anesthetic around the median, radial, ulnar and musculocutaneous nerves. The volume injected per nerve can vary from 5 to 8 ml depending on the visual appreciation during the injection.

Active Comparator: Truncal ALR

Procedure

The anesthetic protocol in truncal block consists in injecting the local anesthetic around the median and ulnar nerves by a puncture performed at the elbow or forearm (depending on the practitioner's experience). The volumes injected remain the same and the puncture is also performed under ultrasound guidance. Additional local anesthesia is administered by injecting an additional 5 ml above the wrist flexion line to block the sensory territory of the musculocutaneous nerve.

Primary outcomes

  1. Evaluation of the patient's pain intraoperatively at the surgical site.

    Time frame: Within 24 hours after intervention

    Evaluation of the patient's pain, at the level of the operative site by a visual analog scale from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain".

Secondary outcomes

  1. Visual Analog Scale for intraoperative pain at the surgical site

    Time frame: intraoperative

    The assessment of pain at the surgical site will be evaluated using a 10-point visual analog scale score from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"

  2. Satisfaction scores

    Time frame: Within 24 hours after intervention

    Satisfaction scores according to the forms provided in the appendices of the anaesthetist and the surgeon

  3. Satisfaction scores

    Time frame: One day after intervention

    Satisfaction scores according to the forms provided in the appendices of the patient

  4. Assessment of the patient's overall pain after surgery

    Time frame: One day after intervention

    Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"

  5. Assessment of the patient's overall pain after surgery

    Time frame: One month after intervention

    Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"

  6. Assessment of the patient's overall pain after surgery

    Time frame: Three months after intervention

    Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"

  7. Assessment of the patient's overall pain after surgery

    Time frame: Six months after intervention

    Assessment of the patient's overall pain after surgery using a numerical scale (EN) from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain"

  8. Evaluation of the return to work after surgery

    Time frame: Within 24 hours after intervention

    Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"

  9. Evaluation of the return to work after surgery

    Time frame: One month after intervention

    Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"

  10. Evaluation of the return to work after surgery

    Time frame: Three months after intervention

    Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"

  11. Evaluation of the return to work after surgery

    Time frame: Six months after intervention

    Evaluation thanks to the Quick-DASH Questionnaire from 0 to 100 where 0 equals to "No disability" and 100 equals to "Most severe disability and reduced function"

  12. Evaluation of the quality of life

    Time frame: Baseline (Before the anesthesia)

    Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"

  13. Evaluation of the quality of life

    Time frame: One month after intervention

    Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"

  14. Evaluation of the quality of life

    Time frame: Three months after intervention

    Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"

  15. Evaluation of the quality of life

    Time frame: Six months after intervention

    Evaluation thanks to the SF-36 from 0 to 100 where 0 equals to "Poor Health" and 100 equals to "Good Health"

  16. Evaluation of the use of analgesics in the postoperative situation

    Time frame: One day after intervention

    The use of analgesics will be collected until D+1 by defining the following levels of analgesic intake:

    • Level I: use of a paracetamol-type analgesic, up to 4 g/day
    • Level II: use of another type of analgesic (Tramadol or Lamaline®)
  17. Evaluation of the failure rates of different anesthesia procedures.

    Time frame: Within 24 hours after intervention

    The following were considered procedural failures: need for intravenous sedation for all 3 groups, need to inflate the tourniquet (applied as a preventive measure) for the WALANT group only.

  18. Evaluation of the operative time.

    Time frame: During surgery

    Operating time defined as the time from skin incision to skin closure (in minutes)

  19. Evaluation of the hospitalization length.

    Time frame: Within 24 hours after intervention

    Hospitalization length defined as the time from the patient's admission to the end of the hospitalization (in hours)

  20. Evaluation of the time to release of anesthesia.

    Time frame: Within 24 hours after intervention

    Time to release of anesthesia defined as the time from the placement of anesthesia to the release of motor (ability to clench/unclench the hand) and sensory (disappearance of tingling) anesthesia

  21. Evaluation of the safety of different types of anesthesia.

    Time frame: One month after intervention

    Collection of postoperative adverse events.

Sponsors and collaborators

Lead sponsor

Elsan

Other

Registry information

Official study title

WALANT (Wide Awake Local Anaesthesia With No Tourniquet) Procedure in Carpal Tunnel Release: a Prospective Randomized Study

Important dates

Study start
2020
Primary completion
2022
Study completion
2023
First posted
Jun 14, 2021
Registry last updated
Mar 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.